These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 18277387

  • 1. Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-gamma ligands in ovariectomized obese rats.
    Yoshioka K, Wakino S, Homma K, Kanda T, Tatematsu S, Hasegawa K, Sugano N, Ito O, Omata K, Saruta T, Hayashi K.
    Obesity (Silver Spring); 2008 May; 16(5):965-71. PubMed ID: 18277387
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats.
    Zhou Y, Huang H, Chang HH, Du J, Wu JF, Wang CY, Wang MH.
    J Pharmacol Exp Ther; 2006 Apr; 317(1):11-8. PubMed ID: 16339392
    [Abstract] [Full Text] [Related]

  • 4. PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats.
    Zhao X, Li LY.
    Am J Nephrol; 2008 Apr; 28(4):598-606. PubMed ID: 18277067
    [Abstract] [Full Text] [Related]

  • 5. Inability to upregulate cytochrome P450 4A and 2C causes salt sensitivity in young Sprague-Dawley rats.
    Sankaralingam S, Desai KM, Glaeser H, Kim RB, Wilson TW.
    Am J Hypertens; 2006 Nov; 19(11):1174-80. PubMed ID: 17070431
    [Abstract] [Full Text] [Related]

  • 6. Rofecoxib decreases renal injury in obese Zucker rats.
    Dey A, Maric C, Kaesemeyer WH, Zaharis CZ, Stewart J, Pollock JS, Imig JD.
    Clin Sci (Lond); 2004 Dec; 107(6):561-70. PubMed ID: 15307815
    [Abstract] [Full Text] [Related]

  • 7. Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.
    Oliveira AC, Bertollo CM, Rocha LT, Nascimento EB, Costa KA, Coelho MM.
    Eur J Pharmacol; 2007 Apr 30; 561(1-3):194-201. PubMed ID: 17343847
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet.
    Zhou Y, Lin S, Chang HH, Du J, Dong Z, Dorrance AM, Brands MW, Wang MH.
    Am J Hypertens; 2005 Apr 30; 18(4 Pt 1):530-7. PubMed ID: 15831364
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner.
    Birnbaum Y, Long B, Qian J, Perez-Polo JR, Ye Y.
    Basic Res Cardiol; 2011 May 30; 106(3):431-46. PubMed ID: 21360043
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats.
    Zanchi A, Perregaux C, Maillard M, Cefai D, Nussberger J, Burnier M.
    Am J Physiol Endocrinol Metab; 2006 Dec 30; 291(6):E1228-34. PubMed ID: 16835400
    [Abstract] [Full Text] [Related]

  • 17. The effects of PPAR-gamma ligand pioglitazone on platelet aggregation and arterial thrombus formation.
    Li D, Chen K, Sinha N, Zhang X, Wang Y, Sinha AK, Romeo F, Mehta JL.
    Cardiovasc Res; 2005 Mar 01; 65(4):907-12. PubMed ID: 15721871
    [Abstract] [Full Text] [Related]

  • 18. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
    Toyoda T, Kamei Y, Kato H, Sugita S, Takeya M, Suganami T, Ogawa Y.
    Obesity (Silver Spring); 2008 Jun 01; 16(6):1199-207. PubMed ID: 18356826
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.